Curaderm Europe Limited

The main curative field of Curaderm Europe Limited is oncology. Relative to time, science has progressed considerably over the last decades. In the medical field this has resulted in humans living longer, healthier lives. More specifically, medical research has investigated the improvement of technologies to preserve the vitality of the body's largest organ, the skin. Our unparalleled commitment to research and development in skin cancer treatments and their delivery systems has resulted in the creation of exclusive state-of-the-art anti-cancer and anti-ageing products. An ideal skin cancer therapy is one that when the therapy is applied topically to an exposed skin cancer it selectively induces the tumour to undergo apoptosis without causing damage to the surrounding healthy skin cells. In practice this has long eluded cancer therapy. The anticancer drugs available are neither selective nor penetrative. Now it is shown with CuradermBEC5 that it is possible to eliminate skin cancer without harming surrounding healthy skin cells. Today, because of rigorous research, an almost ideal skin cancer therapy is available that is specific in killing cancer cells but not normal cells, has little adverse side effects, is much less expensive than other treatments, very simple to use, and most importantly, works, restoring healthy, unblemished skin virtually every time with exceptional cosmetic outcomes.
Social Link - Linkedin: http://www. linkedin.com/company /curaderm-europe-limited
Keywords: wellness & fitness services